A SPECIALIST Hartlepool medical firm has unveiled plans to create even more jobs.
Bosses at Hart Biologicals, based in the Rivergreen Business Centre on the Queens Meadow Business Park, revealed that they will be taking on six extra workers - on top of the 13 new posts they have just announced.
Managing director Alby Pattison told the Hartlepool Mail that the firm, which specialises in making the reagents which are used to investigate the blood clotting function in patients, had sealed a deal with a German firm called TEM, to start in January next year.
The Munich-based company wants Hart Biologicals to increase its manufacturing capacity to supply more of its existing products, and look at ways of developing new reagents for trauma and surgical units.
Mr Pattison said the growth of the company “excites me”. We started with three people in 2003 and when we came here to Queens Meadow in 2009 we had 12 staff,” he added.
On the day the firm announced its expansion into a second unit at Rivergreen - complete with an extra 13 staff - Mr Pattison revealed: “We are already looking for another six people and that will take us to 39.”
“The expansion by Hart Biologicals demonstrates how the Tees Valley Enterprise Zone is succeeding in delivering growth and jobs.”
He said: “We need to increase the quantities of what we already make, but we are also having to put into production the new products that we are developing here. We are gearing up for achange in our production capacity.”
The Queens Meadow Business Park is part of the Tees Valley Enterprise Zone.
Stephen Catchpole, managing director at the local enterprise partnership Tees Valley Unlimited, said: “The expansion by Hart Biologicals demonstrates how the Tees Valley Enterprise Zone is succeeding in delivering growth and jobs.”
Peter Candler, managing director of Rivergreen Developments, who owns the units occupied by Hart Biologicals, commented: “The Rivergreen Business Centre at Queens Meadow was conceived as a high quality development that would provide first class workspace for ambitious and forward thinking companies.
“Hart Biologicals fits this profile perfectly and we are delighted that they have expanded and taken on an additional unit for their research and development work.”
Since the company was formed in 2003 it has quickly earned a reputation as one of the most highly-rated operations of its kind in the UK. It exports products to many countries around the world and its main end-users are hospitals, GP surgeries and pharmacies.
Queens Meadow Business Park is one of eight key sites identified in the Hartlepool Vision which is Hartlepool Council’s blueprint to spark regeneration and create jobs.